| Literature DB >> 21491965 |
Xiayuan Liang1, Ashley Jones, Roger H Giller, Karen Swisshelm, Loris McGavran, Lynne Meltesen, Billie Carstens, Amy N McGranahan, Edythe A Albano.
Abstract
BCL2 and MYC are oncogenes often deregulated in lymphomas. Concurrent IGH-BCL2 and MYC translocations result in a highly aggressive behavior of these tumors. Both primary breast lymphoma and lymphoma with concurrent BCL2-IGH and MYC translocations are rare and are primarily seen in adult patients. As a result of limited clinician experience and the condition's rarity, it poses a great challenge to pediatric pathologists and oncologists in terms of making an accurate diagnosis and choosing better treatment regimens. In this article, we report a case of an adolescent patient who presented with high-grade breast lymphoma with concurrent BCL2-IGH and MYC-IGL translocations, and we review the clinical, pathological, and genetic features; management strategies; and outcomes associated with this unusual neoplasm.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21491965 DOI: 10.2350/10-10-0927-CR.1
Source DB: PubMed Journal: Pediatr Dev Pathol ISSN: 1093-5266